CV Therapeutics

URI: https://gptkb.org/entity/CV_Therapeutics
GPTKB entity
Statements (16)
Predicate Object
gptkbp:instanceOf gptkb:biotechnology
gptkbp:acquiredBy gptkb:Gilead_Sciences
gptkbp:acquisitionYear 2009
gptkbp:country gptkb:United_States
gptkbp:focus cardiovascular drugs
gptkbp:foundedYear 1992
gptkbp:founder gptkb:Luis_Belardinelli
gptkbp:headquartersLocation gptkb:Palo_Alto,_California,_United_States
https://www.w3.org/2000/01/rdf-schema#label CV Therapeutics
gptkbp:industry gptkb:biotechnology
gptkbp:notableProduct gptkb:Lexiscan
gptkb:Ranolazine
gptkbp:stockExchange gptkb:NASDAQ
gptkbp:stockSymbol gptkb:CVTX
gptkbp:bfsParent gptkb:Gilead_Sciences
gptkbp:bfsLayer 5